Abstract

Summary

Wearing blue-cut glasses at night to reduce ipRGC stimulation showed a trend toward fewer migraine headache days over a 4-week period, suggesting that evening light management may serve as a prophylactic tool for migraine sufferers. For lighting designers and healthcare providers, this supports the case for limiting short-wavelength (blue) light exposure in evening environments, particularly in clinical and residential settings for photosensitive individuals.
Abstract

Key Findings

  • Mean headache days decreased from 8.7±5.03 days (pre-intervention) to 7.0±4.37 days (post-intervention) over 4 weeks of nightly blue-cut glass use (n=10)
  • No side effects were reported among any of the 10 participants
  • Results were described as a trend rather than statistically significant, likely due to the small sample size
  • The glasses specifically targeted ipRGC (intrinsically photosensitive retinal ganglion cell) stimulation as the mechanistic rationale
Categories

Categories

The Science of Light: Study directly investigates ipRGC stimulation as a mechanism for migraine exacerbation and uses blue-cut glasses to modulate this pathway.
Sleep & Circadian Health: Blue-cut glasses worn at night reduce ipRGC-mediated light stimulation, with implications for circadian light management in migraine patients.
Mood & Mental Wellness: Migraine reduction through light management has direct implications for patient wellbeing and quality of life as measured by HIT-6 scores.
Authors

Author(s)

M Tatsumoto, E Suzuki, M Nagata, K Suzuki
Publication Date

Publication Year

2023
Citations

Number of Citations

3
View more publications